Rare diseases
Investigational molecules
Locations
Back to Belgium1 898 clinical trials in Mechelen, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Continued Ceritinib Treatment for Patients with ALK Positive Non-Small Cell Lung Cancer
BelgiumStudy on the Effectiveness and Safety of Depemokimab vs. Mepolizumab for Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis
BelgiumStudy on the Effects of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis Who Cannot Tolerate Ursodeoxycholic Acid
BelgiumStudy on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments
BelgiumStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension
BelgiumLong-Term Safety Study of Valoctocogene Roxaparvovec for Patients with Severe Hemophilia A
BelgiumStudy on Vedolizumab for Children with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
BelgiumStudy Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
BelgiumStudy Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients
BelgiumStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Current studies focus on respiratory infections and preventive measures, including innovative vaccine trials for RSV and influenza in various age groups. Research encompasses both standalone treatments and combination therapies.
Special attention is given to protecting vulnerable populations, particularly adults over 60 years of age.
Groundbreaking research in lung cancer treatment, particularly focusing on non-small cell and small cell variants. Studies evaluate novel therapeutic approaches including immunotherapy combinations.
Investigations include both first-line treatments and advanced therapy options.
Studies addressing cardiovascular disease and related conditions, including trials for hypertriglyceridemia and stroke prevention in atrial fibrillation patients.
Focus on both preventive measures and treatment of existing conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
